Award

Why is there an increased risk of severe adverse perinatal outcomes after the use of clomiphene citrate for infertility treatment?

Description: Clomiphene citrate (CC) has been a first line treatment for female infertility internationally since the 1960’s. However, safety studies using routine prescribing practices were never performed, and numerous data sources now indicate that CC is associated with major adverse outcomes if the fetus is inadvertently exposed. We are linking prescription data to perinatal outcomes to confirm how CC is associated with adverse events so as to inform prescriber and practice change.
Amount: A$562,200
Funding type: research
Funder scheme: Project Grants - Standard Project Grant
Start date: 2018-01-01
End date: 2020-12-31
Investigator: Michael Davies (lead)
Institutions: The University of Adelaide, University of Adelaide
Field: Medicine
Funded outputs count: 4
Funder award ID: 1147683
OpenAlex ID: G7053564945